Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Preeclampsia: full-pipeline trial registry
29 of 49 indexed Preeclampsia trials are currently recruiting.
Corpus placement: #281 of 28,707 conditions by registered trial count.
49 US clinical trials · 29 currently recruiting · #281 of 28,707 conditions by registered trial count
Preeclampsia: 49 US clinical trials tracked, 29 recruiting.
Preeclampsia is the subject of 49 registered US clinical trials on ClinicalTrials.gov, 29 of them currently open to new participants. 8 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is Anna Stanhewicz, PhD, running 4 of these trials.
Enrollment posture brief
Registry condition preeclampsia
OPEN 29 | RECR 59% | LATE 8 | EARLY 10 | RANK #281 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Movement Disorders (59% recruiting · 27 trials)
Preeclampsia lists 29 open slots (59% of 49 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Preeclampsia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Preeclampsia is recruiting above its size-band peers.
29 of 49 indexed trials (59.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Preeclampsia trials is spread across many organizations.
Anna Stanhewicz, PhD accounts for 4 of 49 trials (8.2%). 35 distinct sponsors appear on at least one study for this condition label.
-
Typical Preeclampsia enrolment sits around 132 participants.
Median target enrolment is 132 among the 49 trials that report a genuine target (sentinel values excluded). 18 of those (36.7%) plan for fewer than 100 participants.
-
Preeclampsia splits between interventional and observational designs.
34 interventional and 15 observational studies make up this index (69.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
49 total, page 1 of 1
The Preeclampsia Registry
Preeclampsia Foundation
NCT06377878
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Ohio State University
NCT06468202
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
The George Washington University Biostatistics Center
NCT03487185
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
University of Pennsylvania
NCT06408181
Multi-Omics for Maternal Health After Preeclampsia
University of California, San Diego
NCT06340152
EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)
Ohio State University
NCT06249178
Exercise Testing After Preeclampsia
Vanderbilt University Medical Center
NCT06741436
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
University of Pittsburgh
NCT05655936
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Thomas Jefferson University
NCT06826859
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
Christiana Care Health Services
NCT06180811
Physical Activity to Mitigate PreEclampsia Risk
East Carolina University
NCT06319014
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
Massachusetts General Hospital
NCT07041281
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
University of Michigan
NCT06785116
Mechanisms of Pregnancy Vascular Adaptations
University of Wisconsin, Madison
NCT03806283
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
University of Alabama at Birmingham
NCT05676476
Predictors of Aspirin Failure in Preeclampsia Prevention
Rockefeller University
NCT05709483
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
Northwestern University
NCT06523569
Preventing Obstetric Complications With Dietary Intervention
Medical College of Wisconsin
NCT06320054
Effects of High Altitude on AMPK Activation
University of Colorado, Denver
NCT02391519
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
Ohio State University
NCT06632379
Exosome Cargo From Preeclampsia Patients
University of Alabama at Birmingham
NCT04154332
Prenatal Aspirin and Postpartum Vascular Function
Anna Stanhewicz, PhD
NCT05653973
Placental Imaging Techniques
Carilion Clinic
NCT06861309
Treatment With Aspirin After Preeclampsia: TAP Trial
Malamo Countouris
NCT06281665
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
University of Tennessee Graduate School of Medicine
NCT06802861
Daily Aspirin Treatment After Preeclampsia
Anna Stanhewicz, PhD
NCT06168461
Vascular Effects of High-Salt After Preeclampsia
Anna Stanhewicz, PhD
NCT06749418
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
University of Utah
NCT05826925
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Mayo Clinic
NCT06333652
MIRACLE of LIFE Study
Mirvie
NCT06074601
Low Dose Aspirin Alerts in High-Risk Pregnancies
Geisinger Clinic
NCT05802940
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
JHSPH Center for Clinical Trials
NCT04551807
Preeclampsia Postpartum Antihypertensive Treatment
Medical College of Wisconsin
NCT04298034
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)
The Miriam Hospital
NCT02412696
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
University of Virginia
NCT05514847
MR and Inflammation After Preeclampsia
Anna Stanhewicz, PhD
NCT07345845
Preeclampsia Educational Program Study (PrEPS)
MemorialCare Health System
NCT06373367
Family Study on Preeclampsia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT00344162
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
University of Mississippi Medical Center
NCT00583635
Nudge to Drive Transitions of Care
University of Pennsylvania
NCT04660032
Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
University of Pittsburgh
NCT03749746
Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)
Thomas Jefferson University
NCT04295850
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
University of Pennsylvania
NCT04119232
App-based Remote Blood Pressure Monitoring
Women and Infants Hospital of Rhode Island
NCT05595629
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
University of Colorado, Denver
NCT02221830
Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients
Milton S. Hershey Medical Center
NCT01261884
Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)
University of Mississippi Medical Center
NCT00653809
Pravastatin for Prevention of Preeclampsia
The University of Texas Medical Branch, Galveston
NCT01717586
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
University of Colorado, Denver
NCT02384226
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Preeclampsia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Preeclampsia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Preeclampsia page
49 registered trials, 29 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 29 Preeclampsia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Anna Stanhewicz, PhD sponsors the most Preeclampsia trials on record, review their full trial history before evaluating a specific study. See Anna Stanhewicz, PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Preeclampsia condition card totals 49 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.